[{"Assets_0_Q2_USD":9206257000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":237043000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":233331000.0,"StockholdersEquity_0_Q2_USD":-617042000.0,"RevenuesConverted_2_Q2_USD":1431749000.0,"RevenuesConverted_1_Q2_USD":713830000.0,"NetIncomeLossConverted_1_Q2_USD":-15500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":231941000.0,"NetIncomeLossConverted_2_Q2_USD":26024000.0,"EarningsPerShareDiluted_2_Q2_USD":0.11,"EarningsPerShareDiluted_1_Q2_USD":-0.07,"EarningsPerShareBasic_2_Q2_USD":0.11,"EarningsPerShareBasic_1_Q2_USD":-0.07,"CommonStockSharesOutstanding_0_Q2_shares":233496634.0,"CommonStockSharesConverted_0_Q2_shares":233496634.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":398816000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":233331000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]